Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Xiaohu Ouyang is active.

Publication


Featured researches published by Xiaohu Ouyang.


Tetrahedron | 1999

Solid support synthesis of 2-substituted dibenz[b,f]oxazepin-11(10H)-onesvia SNAr methodology on AMEBA resin

Xiaohu Ouyang; Nuria A. Tamayo; Alexander Kiselyov

Abstract Efficient assembly of dibenz[b,f]oxazepin-11(10H)-ones utilizing the SNAr of fluorine in 2-fluoro-5-nitrobenzoic acid with the OH of various 2-aminophenols on solid support is reported. The flexibility of this synthesis, as well as the excellent purity (>90%) of the final products are the distinctive characteristics of the resulting library.


Tetrahedron | 2000

Novel and Highly Efficient Synthesis of Substituted Dibenz[b,g]1,5-oxazocines. A Direct Comparison of the Solution versus Solid-Phase Approach

Xiaohu Ouyang; Zhidong Chen; Longbin Liu; Celia Dominguez; Alexander Kiselyov

Abstract We describe a novel and highly efficient synthesis of substituted dibenz[ b , g ]1,5-oxazocines. The procedure is based on the S N Ar of fluoride with the phenolic hydroxide of the properly assembled acyclic intermediate. A direct comparison of the solution-phase vs the solid-phase synthesis has been conducted. The speed of the synthesis, the purity of the desired eight-membered heterocycles (>95%), as well as the diversity of the resultant library are definite advantages of the solid-phase procedure. Yields of dibenz[ b , g ]1,5-oxazocines synthesized via the solid-phase approach were generally better, while the purity of the products synthesized by both methods were identical.


ACS Medicinal Chemistry Letters | 2010

Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo Efficacy.

Eugene L. Piatnitski Chekler; Alexander S. Kiselyov; Xiaohu Ouyang; Xiaoling Chen; Vatee Pattaropong; Ying Wang; M. Carolina Tuma; Jacqueline F. Doody

In an effort to develop potent, orally bioavailable compounds for the treatment of neoplastic diseases, we developed a class of dual VEGFR-2 kinase and tubulin inhibitors. Targeting the VEGFR receptor kinase and tubulin structure allows for inhibition of both tumor cells and tumor vasculature. Previously, a combination of two compounds, a VEGF receptor tyrosine kinase inhibitor and tubulin agent, was demonstrated to produce an enhanced antitumor response in animal studies. We have reaffirmed their results, with the added benefit that both activities are found in one compound.


Tetrahedron Letters | 1999

Novel synthesis of dibenzo[b,g]1,5-oxazocines

Xiaohu Ouyang; Alexander Kiselyov

An efficient approach to dibenzo[b,g]1,5-oxazocines on solid support is described. The procedure is based on the intramolecular nucleophilic aromatic substitution of fluorine from the derivatives of 2-fluoro-5-nitrobenzaldehyde with the OH function of immobilized phenols. Good yields, and excellent purities of the targeted heterocycles are the advantages of the reported procedure.


Tetrahedron | 1999

Fast and efficient synthesis of substituted dibenz[b,f]oxazocines on solid support

Xiaohu Ouyang; Alexander Kiselyov

Abstract An efficient synthesis of substituted dibenzazocines on solid support is described. The targeted heterocycles are assembled via the nucleophilic aromatic substitution of fluorine in 2-fluoro-5-nitrobenzoic acid with the OH function of the immobilized polysubstituted phenols. High yields and excellent purities of the final products are the distinct characteristics of the resultant 15-member library.


Archive | 2002

Substituted alkylamine derivatives and methods of use

Guoqing Chen; Jeffrey Adams; Jean E. Bemis; Shon Booker; Guolin Cai; Lucian Di Pietro; Celia Dominguez; Daniel Elbaum; Julie Germain; Stephanie Geuns-Meyer; Michael Handley; Qi Huang; Joseph L. Kim; Tae-Seong Kim; Alexander Kiselyov; Xiaohu Ouyang; Vinod F. Patel; Leon M. Smith; Markian Stec; Andrew Tasker; Ning Xi; Shimin Xu; Chester Chenguang Yuan; Michael Croghan


Archive | 2002

Substituted amine derivatives and their use for the treatment of angiogenesis

Guoqing Chen; Jeffrey Adams; Jean E. Bemis; Michael Croghan; Lucian V. Dipietro; Celia Dominguez; Daniel Elbaum; Julie Germain; Qi Huang; Joseph L. Kim; Xiaohu Ouyang; Vinod F. Patel; Leon M. Smith; Andrew Tasker; Ning Xi; Shimin Xu; Chester Chenguang Yuan; Tae-Seong Kim


Journal of Medicinal Chemistry | 2003

Structure-activity relationship of (1-aryl-2-piperazinylethyl)piperazines: antagonists for the AGRP/melanocortin receptor binding.

Premilla Arasasingham; Christopher Fotsch; Xiaohu Ouyang; Mark H. Norman; Michael G. Kelly; Kevin Lee Stark; Bill Karbon; Clarence Hale; James W. Baumgartner; Martha Zambrano; Janet Cheetham; Nuria A. Tamayo


Archive | 2009

Substituted alkylamine derivative, and method for using the same

Jeffrey Adams; Jean E. Bemis; Shon Booker; Guolin Cai; Guoqing Chen; Michael Croghan; Lucian Dipietro; Celia Dominguez; Daniel Elbaum; Julie Germain; Stephanie Geuns-Meyer; Michael Handley; Qi Huang; Joseph L. Kim; Tae-Seong Kim; Alexander Kiselyov; Xiaohu Ouyang; Vinod F. Patel; Leon M. Smith; Markian Stec; Andrew Tasker; Ning Xi; Shimin Xu; Chester Chenguang Yuan; アレクサンダー・キセリヨフ; アンドリユー・タスカー; クオチン・チエン; クオリン・カイ; ジーン・ビーミス; ジエフリー・アダムズ


Archive | 2008

Substituted 2-amino-3-nicotin amide derivatives and pharmaceutical compositions comprising the same

Jeffrey Adams; Jean E. Bemis; Guoqing Chen; Lucian Dipietro; Celia Dominguez; Daniel Elbaum; Qi Huang; Joseph L. Kim; Xiaohu Ouyang; Vinod F. Patel; Leon M. Smith; Andrew Tasker; Ning Xi; Shimin Xu; Chester Chenguang Yuan; Michael Croghan; Julie Germain; Tae-Seong Kim

Collaboration


Dive into the Xiaohu Ouyang's collaboration.

Researchain Logo
Decentralizing Knowledge